Galapagos nv

Galapagos nv

Galapagos has formed its own archipelago of drugs to treat bone and joint ailments and other diseases. The company uses its proprietary genomic drug-discovery technology to develop medicines to treat rheumatoid arthritis, osteoarthritis, and osteoporosis. Galapagos' pharma services subsidiaryBioFocus DPI offers collaborative drug-discovery services to other pharmaceutical companies. Its drug discovery division works with partners to find, test, and market new drugs. The company's pharmaceutical collaborators include top drugmakers GlaxoSmithKline, Eli Lilly, Merck, and Janssen Pharmaceutica, part of Johnson & Johnson. Galapagos has about 40 projects in its R&D pipeline, most of them through these partnerships.

Contact Details

Office Address

Galapagos nv
Generaal De Wittelaan L11 A3, Mechelen, Belgium B-2800
Phone: +32-15-34-29-00
Fax: +32-15-34-29-01

Executives

Chairman

Rajesh B. (Raj) Parekh

CEO and Director

Onno van de Stolpe

Business Reviews for Galapagos nv

Related Companies